Anterix (ATEX) shares were up 14% in Tuesday's premarket session after it said that it hired Morgan Stanley (MS) to conduct a strategic review process for the company.
The company said Morgan Stanley will review pricing, payment, and ownership terms along with potential collaborations with strategic partners on additional products and services.
Anterix said there is no deadline or timetable for when the strategic review will be completed.
Price: 32.54, Change: +4.02, Percent Change: +14.08
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.